A Pharmacokinetic Study of an Experimental Paracetamol Formulation

• Status: Completed
• Trial end date: 2009-08-01
• Target enrollment: 0
• Participant gender: All

Summary

This PK study is designed to show bioequivalence between the study treatments.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: GlaxoSmithKline
• Treatments: Acetaminophen; Caffeine

Criteria

Inclusion Criteria:

• Healthy volunteer

Exclusion Criteria:

-